Systemic lupus erythematous with recurrent Guillain-Barré-like syndrome treated with intravenous immunoglobulins

Lupus

Volumn 12, Issue 11, 2003, Pages 857-859

  Lewis, M ^a   Gibson, T ^a,b  

^a GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

^b GUY S HOSPITAL   (United Kingdom)

Author keywords

Acute peripheral neuropathy; Ascites; Intravenous immunoglobulins; Tetraplegia

Indexed keywords

AZATHIOPRINE; CYCLOPHOSPHAMIDE; IMMUNOGLOBULIN; METHOTREXATE; PREDNISONE;

ADULT; AFRICA; ARTICLE; ASCITES; ASSISTED VENTILATION; CASE REPORT; CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY; CLINICAL FEATURE; DEATH; DIAGNOSTIC ERROR; DIAGNOSTIC IMAGING; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE COURSE; DRUG EFFICACY; DRUG RESPONSE; DRUG WITHDRAWAL; ELECTROMYOGRAM; ETHNIC GROUP; GENERAL CONDITION IMPROVEMENT; GUILLAIN BARRE SYNDROME; HISTOLOGY; HUMAN; IMMUNOTHERAPY; KIDNEY BIOPSY; LABORATORY TEST; LISTERIA; MAINTENANCE THERAPY; MALE; MENINGITIS; MIXED CONNECTIVE TISSUE DISEASE; MUSCLE BIOPSY; MYOSITIS; NERVE CONDUCTION; PARALYSIS; PERIPHERAL NEUROPATHY; PHYSICAL EXAMINATION; PLASMAPHERESIS; PRIORITY JOURNAL; RECURRENT DISEASE; SEPSIS; SYSTEMIC LUPUS ERYTHEMATOSUS; TREATMENT OUTCOME;

ACUTE DISEASE; ADULT; ASCITES; GUILLAIN-BARRE SYNDROME; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; RECURRENCE;

EID: 0344875054     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1191/0961203303lu464cr     Document Type: Article

References (14)

1. Gibson T, Myers AR. Nervous system involvement in systemic lupus erythematosus. Ann Rheum Dis 1976; 35: 398-406.
2. McCombe PA, McLeod G, Pollard JD et al. Peripheral sensorimotor and autonomic neuropathy associated with systemic lupus erythematosus. Brain 1987; 110: 533-540.
3. Sivri A, Hasccelik Z, Celiker R, Bacsgoze O. Early detection of neurological involvement in systemic lupus erythematosus patients. Electromyogr Clin Neurophysiol 1995; 35: 195-199.
4. Robson MG, Walport MJ, Davies KA. Systemic lupus erythematosus and acute demyelinating polyneuropathy. Br J Rheumatol 1994; 33: 1074-1077.
5. Matsuki Y, Hidaka T, Matsumoto M, Fukushima K, Suzuki K. Systemic lupus erythematosus demonstrating serum anti-GMI antibody with sudden onset of foot drop as the initial presentation. Intern Med 1999; 38: 729-732.
6. Morgan SH, Kennett RP, Dudley C, Mackworth-Young C, Hull R, Hughes GRV. Acute polyradiculoneuropathy complicating systemic lupus erythematosus. Postgrad Med J 1986; 62: 291-294.
7. Lesprit P, Mouloud F, Bierling P et al. Prolonged remission of SLE associated polyradiculoneuropathy after a single course of intravenous immunoglobulin. Scand J Rheumatol 1996; 25: 177-179.
8. Levy Y, Sherer Y, Ahmed A et al. A study of 20 SLE patients with intravenous immunoglobulin - clinical and serologic response. Lupus 1999; 8: 705-712.
9. Papo T. Polyvalent intravenous immunoglobulins in systemic lupus. Rev Med Interne 1999; 20(Suppl. 4): 414-418.
10. Hahn A. Treatment of chronic inflammatory demyelinating polyneuropathy with intravenous immunoglobulin. Neurology 1998; 51(Suppl. 5): 16-21.
11. Plasma Exchange/Sandoglobulin Guillain Barré Syndrome Trial Group. Randomized trial of plasma exchange, intravenous immunoglobulin and combined treatments in Guillain Barré syndrome. Lancet 1997; 349: 225-230.
12. Sigal LH. Chronic inflammatory polyneuropathy complicating SLE; successful treatment with monthly oral pulse cyclophosphamide. J Rheumatol 1989; 16: 1518-1519.
13. Stangel M, Toyka K, Gold R. Mechanisms of high dose intravenous immunoglobulins in demyelinating diseases. Arch Neurol 1999; 56: 661-663.
14. Yu Z, Lennon V. Mechanism of intravenous immune globulin therapy in antibody-mediated autoimmune disease. N Eng J Med 1999; 340: 227-228.